Mechanisms of apoptosis.

Programmed cell death plays critical roles in a wide variety of physiological processes during fetal development and in adult tissues. In most cases, physiological cell death occurs by apoptosis as opposed to necrosis. Defects in apoptotic cell death regulation contribute to many diseases, including disorders where cell accumulation occurs (cancer, restenosis) or where cell loss ensues (stroke, heart failure, neurodegeneration, AIDS). In recent years, the molecular machinery responsible for apoptosis has been elucidated, revealing a family of intracellular proteases, the caspases, which are responsible directly or indirectly for the morphological and biochemical changes that characterize the phenomenon of apoptosis. Diverse regulators of the caspases have also been discovered, including activators and inhibitors of these cell death proteases. Inputs from signal transduction pathways into the core of the cell death machinery have also been identified, demonstrating ways of linking environmental stimuli to cell death responses or cell survival maintenance. Knowledge of the molecular mechanisms of apoptosis is providing insights into the causes of multiple pathologies where aberrant cell death regulation occurs and is beginning to provide new approaches to the treatment of human diseases.

[1]  Robert L Moritz,et al.  Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins , 2000, Cell.

[2]  G. Landes,et al.  Analysis of human transcriptomes , 1999, Nature Genetics.

[3]  H. Steller,et al.  Induction of apoptosis by Drosophila reaper, hid and grim through inhibition of IAP function , 2000, The EMBO journal.

[4]  J. Abrams An emerging blueprint for apoptosis in Drosophila. , 1999, Trends in cell biology.

[5]  J. Diebold,et al.  Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. , 1998, The American journal of pathology.

[6]  J. Penney,et al.  Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease , 1999, Nature.

[7]  Matthias Mann,et al.  FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[8]  R van Driel,et al.  Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Bertin,et al.  Human CARD4 Protein Is a Novel CED-4/Apaf-1 Cell Death Family Member That Activates NF-κB* , 1999, The Journal of Biological Chemistry.

[10]  Dick D. Mosser,et al.  Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome , 2000, Nature Cell Biology.

[11]  J C Reed,et al.  IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.

[12]  V. Dixit,et al.  Boo, a novel negative regulator of cell death, interacts with Apaf‐1 , 1999, The EMBO journal.

[13]  J. Yanagisawa,et al.  The Molecular Interaction of Fas and FAP-1 , 1997, The Journal of Biological Chemistry.

[14]  G. Salvesen,et al.  Caspases: Intracellular Signaling by Proteolysis , 1997, Cell.

[15]  A. Strasser,et al.  The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. , 1999, Molecular cell.

[16]  P. Branton,et al.  p28 Bap31, a Bcl-2/Bcl-XL- and Procaspase-8–associated Protein in the Endoplasmic Reticulum , 1997, The Journal of cell biology.

[17]  Seamus J. Martin,et al.  Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.

[18]  C. Y. Wang,et al.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.

[19]  D. Goeddel,et al.  Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. , 1999, Science.

[20]  L. Montagnier,et al.  Apoptosis in AIDS. , 1993, Science.

[21]  H. Dohlman,et al.  Cell Division Regulation by BIR1, a Member of the Inhibitor of Apoptosis Family in Yeast* , 2000, The Journal of Biological Chemistry.

[22]  V. Cryns,et al.  Proteases to die for. , 1998, Genes & development.

[23]  N. Thornberry,et al.  The Caspase-3 Precursor Has a Cytosolic and Mitochondrial Distribution: Implications for Apoptotic Signaling , 1998, The Journal of cell biology.

[24]  Xiaodong Wang,et al.  Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.

[25]  Stephen W. Fesik,et al.  NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain , 1996, Nature.

[26]  J C Reed,et al.  IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases , 1998, The EMBO journal.

[27]  B. Aggarwal,et al.  Identification and functional characterization of DR6, a novel death domain‐containing TNF receptor , 1998, FEBS letters.

[28]  S. Seshagiri,et al.  Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3-induced , 1997, Current Biology.

[29]  Arul M. Chinnaiyan,et al.  FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.

[30]  L. Ellerby,et al.  Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Nicholson ICE/CED3-like Proteases as Therapeutic Targets for the Control of Inappropriate Apoptosis , 1996, Nature Biotechnology.

[32]  S. Srinivasula,et al.  CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. , 1997, Cancer research.

[33]  F. Shanahan,et al.  The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand , 1996, The Journal of experimental medicine.

[34]  M. Kastan On the TRAIL from p53 to apoptosis? , 1997, Nature Genetics.

[35]  V. Dixit,et al.  TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling , 1998, FEBS letters.

[36]  M. Moskowitz,et al.  Defects in regulation of apoptosis in caspase-2-deficient mice. , 1998, Genes & development.

[37]  S. Korsmeyer,et al.  Solution Structure of the Proapoptotic Molecule BID A Structural Basis for Apoptotic Agonists and Antagonists , 1999, Cell.

[38]  A. Chinnaiyan,et al.  Signal Transduction by DR3, a Death Domain-Containing Receptor Related to TNFR-1 and CD95 , 1996, Science.

[39]  S. Srinivasula,et al.  Negative regulation of cytochrome c‐mediated oligomerization of Apaf‐1 and activation of procaspase‐9 by heat shock protein 90 , 2000, The EMBO journal.

[40]  Q Cheng,et al.  NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Wallach Apoptosis: Placing death under control , 1997, Nature.

[42]  Michael Karin,et al.  Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.

[43]  V. Dixit,et al.  Apoptosis control by death and decoy receptors. , 1999, Current opinion in cell biology.

[44]  J. Camonis,et al.  A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*) , 1995, The Journal of Biological Chemistry.

[45]  S. Kornbluth,et al.  Scythe: a novel reaper‐binding apoptotic regulator , 1998, The EMBO journal.

[46]  B. Binder,et al.  Cytokine induced expression of porcine inhibitor of apoptosis protein (iap) family member is regulated by NF-kappa B. , 1998, Biochemical and biophysical research communications.

[47]  C. Brady,et al.  The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. , 1998, Journal of immunology.

[48]  John Calvin Reed,et al.  The c‐IAP‐1 and c‐IAP‐2 proteins are direct inhibitors of specific caspases , 1997, The EMBO journal.

[49]  D. Goeddel,et al.  TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. , 1996, Immunity.

[50]  W. Haining,et al.  The proapoptotic function of Drosophila Hid is conserved in mammalian cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[51]  L. del Peso,et al.  RICK, a Novel Protein Kinase Containing a Caspase Recruitment Domain, Interacts with CLARP and Regulates CD95-mediated Apoptosis* , 1998, The Journal of Biological Chemistry.

[52]  R. Meadows,et al.  X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death , 1996, Nature.

[53]  M. Hayden,et al.  Cell death attenuation by `Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex , 1998, Cell Death and Differentiation.

[54]  S. Korsmeyer,et al.  Bax Deletion Further Orders the Cell Death Pathway in Cerebellar Granule Cells and Suggests a Caspase-independent Pathway to Cell Death , 1997, The Journal of cell biology.

[55]  V. Dixit,et al.  RIP2 Is a Novel NF-κB-activating and Cell Death-inducing Kinase* , 1998, The Journal of Biological Chemistry.

[56]  J. Blenis,et al.  FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. , 2000, Immunity.

[57]  J. Tschopp,et al.  Inhibition of Death Receptor Signaling by Flice-Inhibitory Protein as a Mechanism for Immune Escape of Tumors , 1999, The Journal of experimental medicine.

[58]  Lianfa Shi,et al.  The E1B 19K/Bcl-2–binding Protein Nip3 is a Dimeric Mitochondrial Protein that Activates Apoptosis , 1997, The Journal of experimental medicine.

[59]  Yili Yang,et al.  Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. , 2000, Science.

[60]  M. Peter,et al.  DEDD, a novel death effector domain‐containing protein, targeted to the nucleolus , 1998, The EMBO journal.

[61]  Y. Lazebnik,et al.  Crystal structure of Apaf-1 caspase recruitment domain: an alpha-helical Greek key fold for apoptotic signaling. , 1999, Journal of molecular biology.

[62]  Brent R. Stockwell,et al.  An Induced Proximity Model for Caspase-8 Activation* , 1998, The Journal of Biological Chemistry.

[63]  Y. Lazebnik,et al.  Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis. , 1999, Cancer research.

[64]  H. Steller Drosophila p53: meeting the Grim Reaper , 2000, Nature Cell Biology.

[65]  A. Hsueh,et al.  DEFT, a novel death effector domain-containing molecule predominantly expressed in testicular germ cells. , 1998, Endocrinology.

[66]  C. Milliman,et al.  BID: a novel BH3 domain-only death agonist. , 1996, Genes & development.

[67]  H. S. Kim,et al.  Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas. , 1999, Cancer research.

[68]  S. Korsmeyer,et al.  BAX Is Required for Neuronal Death after Trophic Factor Deprivation and during Development , 1996, Neuron.

[69]  J. Blenis,et al.  Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade , 1998, Current Biology.

[70]  Vishva M. Dixit,et al.  RAIDD is a new 'death' adaptor molecule , 1997, Nature.

[71]  F. Marumo,et al.  Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. , 1994, Circulation research.

[72]  G Waksman,et al.  Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[73]  D. Lawrence,et al.  Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. , 2000, Immunity.

[74]  T. Landowski,et al.  Mutations in the Fas antigen in patients with multiple myeloma. , 1997, Blood.

[75]  J C Reed,et al.  Pro-caspase-3 Is a Major Physiologic Target of Caspase-8* , 1998, The Journal of Biological Chemistry.

[76]  A. Kimchi,et al.  Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions , 1998, Oncogene.

[77]  L K Miller,et al.  An exegesis of IAPs: salvation and surprises from BIR motifs. , 1999, Trends in cell biology.

[78]  N. Kabra,et al.  Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1 , 1998, Nature.

[79]  K. Muegge,et al.  Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[80]  D. Vaux,et al.  Solution structure and mutagenesis of the caspase recruitment domain (CARD) from Apaf-1 , 1999, Cell Death and Differentiation.

[81]  John Calvin Reed,et al.  Cytochrome c: Can't Live with It—Can't Live without It , 1997, Cell.

[82]  Y. Goltsev,et al.  Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.

[83]  M. Lenardo,et al.  Molecules involved in cell death and peripheral tolerance. , 1997, Current opinion in immunology.

[84]  S. Srinivasula,et al.  Cytochrome c and dATP-mediated Oligomerization of Apaf-1 Is a Prerequisite for Procaspase-9 Activation* , 1999, The Journal of Biological Chemistry.

[85]  J C Reed,et al.  Mitochondria and apoptosis. , 1998, Science.

[86]  John Calvin Reed,et al.  FAP-1: a protein tyrosine phosphatase that associates with Fas. , 1995, Science.

[87]  J. Downward,et al.  Involvement of FADD and caspase-8 signalling in detachment-induced apoptosis , 1999, Current Biology.

[88]  J C Reed,et al.  Ion Channel Activity of the BH3 Only Bcl-2 Family Member, BID* , 1999, The Journal of Biological Chemistry.

[89]  A. MacKenzie,et al.  The inhibitors of apoptosis (IAPs) and their emerging role in cancer , 1998, Oncogene.

[90]  S. Nagata,et al.  Steering anti-cancer drugs away from the TRAIL , 2000, Nature Medicine.

[91]  H. Müller,et al.  The Drosophila Caspase Inhibitor DIAP1 Is Essential for Cell Survival and Is Negatively Regulated by HID , 1999, Cell.

[92]  Christian Stehlik,et al.  Nuclear Factor (NF)-κB–regulated X-chromosome–linked iap Gene Expression Protects Endothelial Cells from Tumor Necrosis Factor α–induced Apoptosis , 1998, The Journal of experimental medicine.

[93]  Roger Y. Tsien,et al.  Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis , 2000, Nature Cell Biology.

[94]  Emad S. Alnemri,et al.  Negative regulation of the Apaf-1 apoptosome by Hsp70 , 2000, Nature Cell Biology.

[95]  John Calvin Reed,et al.  An Evolutionarily Conserved Family of Hsp70/Hsc70 Molecular Chaperone Regulators* , 1999, The Journal of Biological Chemistry.

[96]  G. Salvesen,et al.  Caspase activation: the induced-proximity model. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[97]  D. Goeddel,et al.  The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.

[98]  J C Reed,et al.  Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. , 1999, Science.

[99]  S. Korsmeyer,et al.  Bax suppresses tumorigenesis and stimulates apoptosis in vivo , 1997, Nature.

[100]  Guy S. Salvesen,et al.  X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.

[101]  Junying Yuan,et al.  Human ICE/CED-3 Protease Nomenclature , 1996, Cell.

[102]  Junying Yuan,et al.  Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β , 2000, Nature.

[103]  J. Bertin,et al.  Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[104]  W I Wood,et al.  Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. , 1997, Science.

[105]  S. Chen,et al.  Diva, a Bcl-2 Homologue that Binds Directly to Apaf-1 and Induces BH3-independent Cell Death* , 1998, The Journal of Biological Chemistry.

[106]  L. Cantley,et al.  Apoptosis: A Bad kinase makes good , 1997, Nature.

[107]  John Calvin Reed,et al.  Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.

[108]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[109]  D. Altieri,et al.  A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.

[110]  S. Gerondakis,et al.  Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. , 1999, Genes & development.

[111]  M. Dyer,et al.  Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor Types , 1999, Cell.

[112]  Guido Kroemer,et al.  Mitochondrial control of cell death , 2000, Nature Medicine.

[113]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[114]  John Calvin Reed Caspases and cytokines: roles in inflammation and autoimmunity. , 1999, Advances in immunology.

[115]  A. Harvey,et al.  Doom, a product of the Drosophila mod(mdg4) gene, induces apoptosis and binds to baculovirus inhibitor-of-apoptosis proteins , 1997, Molecular and cellular biology.

[116]  Junying Yuan,et al.  Solution Structure of BID, an Intracellular Amplifier of Apoptotic Signaling , 1999, Cell.

[117]  Fengzhi Li,et al.  Control of apoptosis and mitotic spindle checkpoint by survivin , 1998, Nature.

[118]  Reed Jc Mechanisms of Bcl-2 family protein function and dysfunction in health and disease. , 1996 .

[119]  Fengzhi Li,et al.  Pleiotropic cell-division defects and apoptosis induced by interference with survivin function , 1999, Nature Cell Biology.

[120]  F. Martinon,et al.  Identification of CARDIAK, a RIP-like kinase that associates with caspase-1 , 1998, Current Biology.

[121]  Keisuke Kuida,et al.  Reduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9 , 1998, Cell.

[122]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[123]  B. Seed,et al.  RIP mediates tumor necrosis factor receptor 1 activation of NF‐kappaB but not Fas/APO‐1‐initiated apoptosis. , 1996, The EMBO journal.

[124]  John Calvin Reed,et al.  Bcl-2 family proteins as ion-channels , 1998, Cell Death and Differentiation.

[125]  Jean-Claude Martinou,et al.  Bid-induced Conformational Change of Bax Is Responsible for Mitochondrial Cytochrome c Release during Apoptosis , 1999, The Journal of cell biology.

[126]  Y. Tsujimoto,et al.  Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.

[127]  J. Flannery,et al.  bcl-2 overexpression reduces apoptotic photoreceptor cell death in three different retinal degenerations. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[128]  N. Copeland,et al.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.

[129]  C. Ferran,et al.  Overexpression of A1, an NF-kappaB-inducible anti-apoptotic bcl gene, inhibits endothelial cell activation. , 1999, Blood.

[130]  A. Fraser,et al.  Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis , 1999, Current Biology.

[131]  Andy J. Minn,et al.  Bcl-xL forms an ion channel in synthetic lipid membranes , 1997, Nature.

[132]  J. Baker,et al.  Characterization of FAP-1 expression and function in thyroid follicular cells. , 1999, Endocrinology.

[133]  R. Meadows,et al.  Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis , 1997, Science.

[134]  W. Kaiser,et al.  Inhibitor of Apoptosis Proteins Physically Interact with and Block Apoptosis Induced by Drosophila Proteins HID and GRIM , 1998, Molecular and Cellular Biology.

[135]  E Ruoslahti,et al.  Integrins and anoikis. , 1997, Current opinion in cell biology.

[136]  John C Reed,et al.  Bcl-2 family proteins , 1998, Oncogene.

[137]  J. Tschopp,et al.  Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.

[138]  Junying Yuan,et al.  Murine Caspase-11, an ICE-Interacting Protease, Is Essential for the Activation of ICE , 1998, Cell.

[139]  Warren Strober,et al.  Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome , 1995, Cell.

[140]  T. Tsuruo,et al.  A human IAP-family gene, apollon, expressed in human brain cancer cells. , 1999, Biochemical and biophysical research communications.

[141]  Junying Yuan,et al.  Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.

[142]  M. Prevost,et al.  Mitochondrial Release of Caspase-2 and -9 during the Apoptotic Process , 1999, The Journal of experimental medicine.

[143]  S. Korsmeyer,et al.  BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.

[144]  J C Reed,et al.  Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases , 1999, The EMBO journal.

[145]  G. Otting,et al.  NMR structure of the death domain of the p75 neurotrophin receptor , 1997, The EMBO journal.

[146]  N. Assa‐Munt,et al.  p75NTR and the concept of cellular dependence: seeing how the other half die , 1998, Cell Death and Differentiation.

[147]  G. Nolan,et al.  Identification of RIP3, a RIP-like kinase that activates apoptosis and NFκB , 1999, Current Biology.

[148]  J. Beckmann,et al.  Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. , 1998, Immunity.

[149]  J C Reed,et al.  Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype , 1997, Science.

[150]  T. Mak,et al.  Apaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development , 1998, Cell.

[151]  C. Thompson,et al.  Bcl-2-family proteins: the role of the BH3 domain in apoptosis. , 1998, Trends in cell biology.

[152]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[153]  A. Davies,et al.  Bax promotes neuronal survival and antagonises the survival effects of neurotrophic factors. , 1996, Development.

[154]  Gerhard Wagner,et al.  Solution Structure of the RAIDD CARD and Model for CARD/CARD Interaction in Caspase-2 and Caspase-9 Recruitment , 1998, Cell.

[155]  Xiaodong Wang,et al.  Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.

[156]  G. Nabel,et al.  CIPER, a Novel NF κB-activating Protein Containing a Caspase Recruitment Domain with Homology to Herpesvirus-2 Protein E10* , 1999, The Journal of Biological Chemistry.

[157]  H. Steller Mechanisms and genes of cellular suicide , 1995, Science.

[158]  John Calvin Reed Double identity for proteins of the Bcl-2 family , 1997, Nature.

[159]  P. Leder,et al.  RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death , 1995, Cell.

[160]  J. Tschopp,et al.  The fight of viruses against apoptosis. , 1998, Current opinion in genetics & development.

[161]  Y. Hsu,et al.  Conformation of the Bax C‐terminus regulates subcellular location and cell death , 1999, The EMBO journal.

[162]  Stephen W. Fesik,et al.  NMR structure and mutagenesis of the FADD (Mort1) death-effector domain , 1998, Nature.

[163]  P. Gluckman,et al.  Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus , 1997, Brain Research.

[164]  John Calvin Reed,et al.  Functional interaction of Fas‐associated phosphatase‐1 (FAP‐1) with p75NTR and their effect on NF‐κB activation , 1999, FEBS letters.

[165]  John Calvin Reed,et al.  Upregulation of bax protein levels in neurons following cerebral ischemia , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[166]  David Wallach,et al.  Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.

[167]  Antony Rodriguez,et al.  Dark is a Drosophila homologue of Apaf-1/CED-4 and functions in an evolutionarily conserved death pathway , 1999, Nature Cell Biology.

[168]  F. Martinon,et al.  Apoptosis: Silencing the death receptors , 1999, Current Biology.

[169]  V. Dixit,et al.  mE10, a Novel Caspase Recruitment Domain-containing Proapoptotic Molecule* , 1999, The Journal of Biological Chemistry.

[170]  R. Kamen,et al.  Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock , 1995, Cell.

[171]  Ruedi Aebersold,et al.  Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.

[172]  L. del Peso,et al.  Nod1, an Apaf-1-like Activator of Caspase-9 and Nuclear Factor-κB* , 1999, The Journal of Biological Chemistry.

[173]  E. Alnemri,et al.  Interaction of the baculovirus anti-apoptotic protein p35 with caspases. Specificity, kinetics, and characterization of the caspase/p35 complex. , 1998, Biochemistry.

[174]  Junying Yuan,et al.  Sealing one's fate: control of cell death in neurons , 1998, Current Opinion in Neurobiology.

[175]  John Calvin Reed,et al.  BCL‐2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy , 1996, Journal of cellular biochemistry.

[176]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[177]  Matthew J. Brauer,et al.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. , 1994, Science.

[178]  F Gambale,et al.  Inhibition of Bax channel-forming activity by Bcl-2. , 1997, Science.

[179]  S. R. Datta,et al.  Cellular survival: a play in three Akts. , 1999, Genes & development.

[180]  D. Goeddel,et al.  FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. , 1998, Science.

[181]  Junying Yuan,et al.  Solution structure of Apaf-1 CARD and its interaction with caspase-9 CARD: a structural basis for specific adaptor/caspase interaction. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[182]  A. Godzik,et al.  BAR: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[183]  R. Warnke,et al.  Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. , 1987, The New England journal of medicine.

[184]  J C Reed,et al.  Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[185]  J. Noel,et al.  Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement , 2000, Nature Structural Biology.

[186]  J C Reed,et al.  A Single BIR Domain of XIAP Sufficient for Inhibiting Caspases* , 1998, The Journal of Biological Chemistry.

[187]  S. Moe,et al.  Opposing Effects of Transmembrane and Soluble FAS Ligand Expression on Inflammation and Tumor Cell Survival , 2000, The Journal of experimental medicine.

[188]  D. Baltimore,et al.  Essential role of CED-4 oligomerization in CED-3 activation and apoptosis. , 1998, Science.

[189]  Hans-Peter Hauser,et al.  A Giant Ubiquitin-conjugating Enzyme Related to IAP Apoptosis Inhibitors , 1998, The Journal of cell biology.

[190]  S. Frisch,et al.  Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis , 1999, Current Biology.

[191]  S. Chiou,et al.  Interleukin 1 beta converting enzyme-like proteases are essential for p53-mediated transcriptionally dependent apoptosis. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[192]  D. Green,et al.  Activation-induced apoptosis in lymphoid systems. , 1992, Seminars in immunology.

[193]  J. Tschopp,et al.  Inhibition of fas death signals by FLIPs. , 1998, Current opinion in immunology.

[194]  J. Yuan,et al.  Transducing signals of life and death. , 1997, Current opinion in cell biology.

[195]  E. Koonin,et al.  Role of CED-4 in the activation of CED-3 , 1997, Nature.

[196]  J. Bertin,et al.  Bovine herpesvirus 4 BORFE2 protein inhibits Fas- and tumor necrosis factor receptor 1-induced apoptosis and contains death effector domains shared with other gamma-2 herpesviruses , 1997, Journal of virology.

[197]  T. Gura How TRAIL Kills Cancer Cells, But Not Normal Cells , 1997, Science.

[198]  D. Vaux,et al.  Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat , 1999, Nature Structural Biology.

[199]  John Calvin Reed,et al.  Evolutionary conservation of apoptosis mechanisms: lepidopteran and baculoviral inhibitor of apoptosis proteins are inhibitors of mammalian caspase-9. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[200]  José Luis de la Pompa,et al.  Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo , 1998, Cell.

[201]  S. Korsmeyer,et al.  Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis , 1999, Nature.

[202]  X. Liu,et al.  An APAF-1·Cytochrome c Multimeric Complex Is a Functional Apoptosome That Activates Procaspase-9* , 1999, The Journal of Biological Chemistry.

[203]  T. Crawford,et al.  The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy , 1995, Cell.

[204]  Bernd Hinzmann,et al.  Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32) , 1999, Nature Genetics.

[205]  J C Reed,et al.  Channel formation by antiapoptotic protein Bcl-2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[206]  N. Thornberry,et al.  A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.

[207]  R. Gentz,et al.  An antagonist decoy receptor and a death domain-containing receptor for TRAIL. , 1997, Science.

[208]  Xiaodong Wang,et al.  Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.

[209]  Stephen W. Fesik,et al.  NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP , 1999, Nature.

[210]  F. Shanahan,et al.  Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer , 1998, The Journal of pathology.

[211]  E. Koonin,et al.  The NACHT family - a new group of predicted NTPases implicated in apoptosis and MHC transcription activation. , 2000, Trends in biochemical sciences.